KMT2A and cancer: In summary, our investigation with a homozygous loss-of-function point mutation in the MLL1 gene in human IPS cells suggests a sophisticated MLL1-fusion cancer model where the loss of MLL1 enzymatic activity, facilitated by a dominant negative mechanism, remodels the chromatin landscape.